Publications by authors named "Brian A Baker"

Claim this Profile
P
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study.
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Melissa Aquino, Kamilia Moalem, Brian A Baker

Clin Res Cardiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
Rishi Chandiramani, Huazhen Chen, Shunsuke Aoi, Gennaro Giustino, Bimmer Claessen, Brian A Baker

Catheter Cardiovasc Interv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.
Zhen Ge, Usman Baber, Bimmer E Claessen, Jaya Chandrasekhar, Rishi Chandiramani, Brian A Baker

J Thromb Thrombolysis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Zhen Ge, Usman Baber, Bimmer E Claessen, Serdar Farhan, Jaya Chandrasekhar, Brian A Baker

Catheter Cardiovasc Interv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna S Kini, Brian A Baker

Can J Cardiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
Mark B Effron, Tracy Y Wang, Gregg C Fonarow, Timothy D Henry, Marjorie E Zettler, Brian A Baker

Catheter Cardiovasc Interv· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Usman Baber, Jaya Chandrasekhar, Samantha Sartori, Melissa Aquino, Annapoorna S Kini, Brian A Baker

JACC Cardiovasc Interv· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna Kini, Samir Kapadia, Brian A Baker

Am Heart J· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study.
Marjorie E Zettler, Eric D Peterson, Lisa A McCoy, Mark B Effron, Kevin J Anstrom, Brian A Baker

Am Heart J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).
Emil L Fosbøl, Christine Ju, Kevin J Anstrom, Marjorie E Zettler, John C Messenger, Brian A Baker

Circ Cardiovasc Interv· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette Smoking, Clopidogrel Responsiveness, and Hemoglobin Level.
Paul A Gurbel, Kevin P Bliden, Brian A Baker, Jeffrey Dahlen, Udaya S Tantry

JACC Cardiovasc Interv· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Larry R Jackson, Eric D Peterson, Lisa A McCoy, Christine Ju, Marjorie Zettler, Brian A Baker

J Am Heart Assoc· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Amit N Vora, Eric D Peterson, Lisa A McCoy, Mark B Effron, Kevin J Anstrom, Brian A Baker

J Am Heart Assoc· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies.
Arun Krishnamoorthy, Eric D Peterson, J David Knight, Kevin J Anstrom, Mark B Effron, Brian A Baker

J Am Heart Assoc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Larry R Jackson, Christine Ju, Marjorie Zettler, John C Messenger, David J Cohen, Brian A Baker

JACC Cardiovasc Interv· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.
Tracy Y Wang, Timothy D Henry, Lisa A McCoy, Peter B Berger, David J Cohen, Brian A Baker

Am Heart J· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Ying Xian, Tracy Y Wang, Lisa A McCoy, Mark B Effron, Timothy D Henry, Brian A Baker

Circulation· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study.
Tracy Y Wang, Timothy D Henry, Mark B Effron, Emily Honeycutt, Connie N Hess, Brian A Baker

Circ Cardiovasc Interv· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors.
Paul A Gurbel, Brian A Baker, William L Bailey, Kevin P Bliden, Udaya S Tantry

Thromb Haemost· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study.
Paul A Gurbel, Kevin P Bliden, Douglas K Logan, Dean J Kereiakes, Kenneth C Lasseter, Brian A Baker

J Am Coll Cardiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel.
Isabell Bernlochner, Tanja Morath, Patricia B Brown, Chunmei Zhou, Brian A Baker

Platelets· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thienopyridine efficacy and cigarette smoking status.
Kevin P Bliden, Brian A Baker, Thomas D Nolin, Young-Hoon Jeong, William L Bailey

Am Heart J· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
Matthew J Price, James S Walder, Brian A Baker, Darell E Heiselman, Joseph A Jakubowski

J Am Coll Cardiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.
Dominick J Angiolillo, Juan Jose Badimon, Jorge F Saucedo, Andrew L Frelinger, Alan D Michelson, Brian A Baker

Eur Heart J· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data.
Baojin Zhu, Mark B Effron, M Pandurang Kulkarni, Ying G Li, Joseph A Jakubowski, Brian A Baker

J Cardiovasc Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis